Add like
Add dislike
Add to saved papers

Ultraviolet Inactivation of Chikungunya Virus.

OBJECTIVE: Chikungunya virus (CHIKV) is a rapidly emerging arbovirus causing millions of infections in more than 40 countries. CHIKV is typically a biosafety level 3 pathogen in many countries and handling of CHIKV requires a high standard of laboratory safety settings. Many studies require the whole virus to be handled in a biosafety level 2 setting. A potential solution for managing this problem is pathogen inactivation without affecting its antigenicity. In the present study, we attempted to inactivate CHIKV by ultraviolet (UV) irradiation.

METHODS: Different UV doses were used to inactivate CHIKV. The replication status of the inactivated virus was verified in cell lines. Western blot, electron microscopy, and immune fluorescence assay were used, respectively, to view the antigenicity, structural integrity, and entry of the virus into cell lines.

RESULTS: The inactivation was complete when a UV dose of 0.09 J/cm2 for 3 × 30 s was used and no change in antigenicity and integrity was observed.

CONCLUSIONS: The study concludes that the UV-inactivated virus is antigenically stable and could be used in biosafety level 2 settings for different experiments.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app